HUP9901454A2 - Ibuprofen adagolási formái - Google Patents

Ibuprofen adagolási formái

Info

Publication number
HUP9901454A2
HUP9901454A2 HU9901454A HUP9901454A HUP9901454A2 HU P9901454 A2 HUP9901454 A2 HU P9901454A2 HU 9901454 A HU9901454 A HU 9901454A HU P9901454 A HUP9901454 A HU P9901454A HU P9901454 A2 HUP9901454 A2 HU P9901454A2
Authority
HU
Hungary
Prior art keywords
dosage form
carbogen
fact
weight
amount
Prior art date
Application number
HU9901454A
Other languages
English (en)
Inventor
Ian Ashley Price
Original Assignee
THE BOOTS Co., P.l.c.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THE BOOTS Co., P.l.c., filed Critical THE BOOTS Co., P.l.c.,
Publication of HUP9901454A2 publication Critical patent/HUP9901454A2/hu
Publication of HUP9901454A3 publication Critical patent/HUP9901454A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgyát szilárd, gázt nem fejlesztő, tablettázőttadagőlási főrma képezi, amely ibűprőfen gyógyszert tartalmazhőrdőzóanyagban, a hőrdőzó magában főglal egy tablettázhatótöltőanyagalkőtó elemet, szétesést elősegítő alkőtóelemmel kőmbinálva,azzal jellemezve, hőgy az ibűprőfen gyógyszer 35 tömeg% vagy annálnagyőbb mennyiségben van jelen az adagőlási főrma tömegére számítva,azzal jellemezve, hőgy a hőrdőzóanyag tartalmaz egy alkálifém-karbőnátőt vagy -hidrőgén-karbőnátőt őlyan mennyiségben, hőgy azadagőlási főrma törőszilárdsága a 64 N és 147 N közötti tartőmánybanlegyen és a szétesési idő kisebb legyen mint 10 min. Az ilyen győrsanszéteső készítmények különösen megfelelőek fájdalőm- éslázcsillapításra. ŕ
HU9901454A 1996-02-21 1997-02-19 Dosage form of ibuprofen HUP9901454A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition

Publications (2)

Publication Number Publication Date
HUP9901454A2 true HUP9901454A2 (hu) 1999-08-30
HUP9901454A3 HUP9901454A3 (en) 2001-04-28

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901454A HUP9901454A3 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Country Status (25)

Country Link
US (1) US20020034540A1 (hu)
EP (1) EP0881899B1 (hu)
JP (2) JP2000507922A (hu)
KR (1) KR19990087084A (hu)
CN (1) CN1215989A (hu)
AT (1) ATE273696T1 (hu)
AU (1) AU722991B2 (hu)
BG (1) BG64165B1 (hu)
CA (1) CA2246344C (hu)
CZ (1) CZ298371B6 (hu)
DE (1) DE69730314T2 (hu)
DK (1) DK0881899T3 (hu)
ES (1) ES2227670T3 (hu)
GB (1) GB9603699D0 (hu)
HU (1) HUP9901454A3 (hu)
IL (1) IL125803A0 (hu)
NO (1) NO983825L (hu)
NZ (1) NZ331416A (hu)
PL (1) PL187383B1 (hu)
PT (1) PT881899E (hu)
RU (1) RU2182000C2 (hu)
SK (1) SK285032B6 (hu)
UA (1) UA55407C2 (hu)
WO (1) WO1997030699A2 (hu)
ZA (1) ZA971446B (hu)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
US20020192161A1 (en) * 2001-04-10 2002-12-19 Fahkreddin Jamali Animal model for evaluating analgesics
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
EP1585500B8 (en) * 2002-12-20 2017-07-26 Auritec Pharmaceuticals Coated particles for sustained-release pharmaceutical administration
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
EA014443B1 (ru) * 2004-06-29 2010-12-30 Никомед Данмарк Апс Фармацевтическая композиция (варианты) и способ ее производства
PT1804772E (pt) * 2004-08-12 2011-12-02 Reckitt Benckiser Healthcare Grânulos que compreendem um fármaco anti-inflamatório não esteróide e um álcool de açúcar feito por extrusão de fundido
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CA2589079A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
DK1850834T3 (da) * 2005-02-09 2014-11-10 Boehringer Ingelheim Int Filmovertrykket tablet indeholdende ibufrofen-lysinat
RU2403033C2 (ru) 2005-03-22 2010-11-10 Лозан Фарма Гмбх Солюбилизированный ибупрофен
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
JP2009508951A (ja) * 2005-09-19 2009-03-05 アルベマール・コーポレーシヨン カリウムイブプロフェンの極めて濃厚な注入可能な水溶液、その製造法および使用
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
EP3449928A1 (en) 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20070521L (fi) * 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US8951562B2 (en) * 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
ES2531929T3 (es) * 2006-12-20 2015-03-20 Teva Women's Health, Inc. Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
EP2291233B1 (en) * 2008-05-09 2019-09-04 Atacama Labs Oy Method for dry granulation
US9629806B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
EP2445486B1 (en) * 2009-06-22 2017-11-08 Wyeth LLC Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
JP6304896B2 (ja) * 2013-07-30 2018-04-04 ライオン株式会社 錠剤
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
CN114105850A (zh) 2014-07-02 2022-03-01 奥布赛瓦股份公司 治疗ot-r活性相关的病症的方法中可用的晶体
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
ES2148175T3 (es) * 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel

Also Published As

Publication number Publication date
CA2246344A1 (en) 1997-08-28
SK114298A3 (en) 1999-01-11
RU2182000C2 (ru) 2002-05-10
ZA971446B (en) 1997-11-25
NO983825D0 (no) 1998-08-20
PT881899E (pt) 2004-12-31
SK285032B6 (sk) 2006-05-04
BG102744A (en) 1999-05-31
ATE273696T1 (de) 2004-09-15
JP2009073847A (ja) 2009-04-09
GB9603699D0 (en) 1996-04-17
PL328465A1 (en) 1999-02-01
WO1997030699A2 (en) 1997-08-28
CN1215989A (zh) 1999-05-05
CA2246344C (en) 2009-01-20
ES2227670T3 (es) 2005-04-01
CZ298371B6 (cs) 2007-09-12
DE69730314T2 (de) 2005-08-18
DK0881899T3 (da) 2004-12-20
BG64165B1 (bg) 2004-03-31
DE69730314D1 (de) 2004-09-23
JP2000507922A (ja) 2000-06-27
NO983825L (no) 1998-10-20
US20020034540A1 (en) 2002-03-21
CZ261798A3 (cs) 1998-11-11
UA55407C2 (uk) 2003-04-15
KR19990087084A (ko) 1999-12-15
AU722991B2 (en) 2000-08-17
IL125803A0 (en) 1999-04-11
HUP9901454A3 (en) 2001-04-28
EP0881899B1 (en) 2004-08-18
WO1997030699A3 (en) 1997-10-09
NZ331416A (en) 2000-02-28
EP0881899A2 (en) 1998-12-09
PL187383B1 (pl) 2004-06-30
AU1793797A (en) 1997-09-10

Similar Documents

Publication Publication Date Title
HUP9901454A2 (hu) Ibuprofen adagolási formái
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
HUP0500509A2 (hu) Azonnali felszabadulást biztosító mikronizált gyógyászati és gyógytáp porok
HUP0103883A2 (hu) Új, késleltetett felszabadulású, orális készítmények
MX9500243A (es) Composicion de liberacion acelerada que contiene bromocriptina.
HU9600599D0 (en) Active principles and gas containing microparticles
GEP20022851B (en) Flash-Melt Oral Dosage Formulation
HUP9802287A2 (hu) Cinkkel és kívánt esetben lizinnel vagy kalciumionnal előkezelt növekedési hormont tartalmazó stabilizált gyógyszerkészítmény
AU2003304237A1 (en) Gel-stabilized nanoparticulate active agent compositions
NZ314442A (en) Extended release formulation comprising venlafaxine hydrochloride, film coating composition
HUP0102206A2 (hu) Delavirdint tartalmazó tabletta formájú készítmény
HUP9900312A2 (hu) Humán és állatgyógyászatban alkalmazott növényekből nyert illóolajokon alapuló gyógyszerkészítmények
MY118371A (en) Tetrahydrolipstatin containing compositions
AU1227899A (en) Osmotic medicament releasing system
HUP9903906A2 (hu) Kelátképző clioquinol felhasználása Alzheimer-kór kezelésére alkalmas gyógyszerkészítmények előállításánál
IL108286A0 (en) Use of anticonvulsants in the treatment of parkinson's disease and parkinsonian syndromes
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
HUP0103454A2 (hu) Entacapont vagy nitecapont és keresztkötésű cellulózszármazékot tartalmazó gyógyászati készítmény
HUP9801227A2 (hu) Monoamin-oxidáz B inhibitorokból álló gyógyászati készítmények és alkalmazásuk
IL125913A0 (en) Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases
BR0109747A (pt) Uso de 5-(2-pirazinil)-4-metil-1-2-ditiol-3-tiona (oltipraz) como um medicamento, composição farmacêutica para a prevenção e tratamento da progressão da fibrose hepática, uso de 5-(2-pirazinil)-4-metil-1, 2-ditiol-3-tiona e método para a prevenção e tratamento da progressão da fibrose e da cirrose hepática
NZ332655A (en) Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
IL136142A0 (en) High drug load immediate and modified release oral dosage formulations and processes for their manufacture

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: RECKITT BENCKISER HEALTHCARE INTERNATIONAL LIM, GB

Free format text: FORMER OWNER(S): THE BOOTS CO., P.L.C.,, GB

Owner name: RECKITT BENCKISER HEALTHCARE (UK) LIMITED, GB

Free format text: FORMER OWNER(S): THE BOOTS CO., P.L.C.,, GB